Palm Venture Studio

Palm Venture Studio is a venture studio rather than a traditional fund, signaled by its ‘venture studios’ positioning. Studios typically build companies in-house, recruiting founding teams against internal theses and providing seed capital, operational infrastructure and shared services in exchange for meaningful equity. The source data carries no disclosed healthcare thesis, AI angle, stage preference, geography or check size. Plausible structure for a studio of this profile is internal-build with initial $250K to $1M of capital and significant equity stakes, followed by external seed rounds. For healthcare founders, Palm is most relevant if you are evaluating an EIR or co-founder opportunity rather than raising for an existing company, or if you have a very early-stage idea where studio infrastructure and co-founding partnership materially de-risk early execution. The firm is a poor fit for founders with an existing team and product looking for a financial lead investor in a competitive round, or for therapeutics, regulated devices and capital-intensive healthcare plays. Studios are also typically generalist unless explicitly sector-specialized, so healthcare expertise depth is unverified here and should not be assumed. Entry is best via direct application or LinkedIn outreach to studio leadership, leading with an explicit articulation of why a studio model versus traditional VC-backed formation is right for the opportunity. Founders engaging Palm should clarify equity expectations, services scope, capital trajectory, exit philosophy and prior healthcare exits before committing.